Baird’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$7.51M Buy
103,383
+329
+0.3% +$23.4K 0.08% 253
2014
Q4
$7.11M Buy
103,054
+32,270
+46% +$2.18M 0.08% 269
2014
Q3
$4.59M Sell
70,784
-494
-0.7% -$31.3K 0.06% 267
2014
Q2
$4.43M Sell
71,278
-22,512
-24% -$1.34M 0.06% 277
2014
Q1
$5.52M Sell
93,790
-10,491
-10% -$585K 0.08% 247
2013
Q4
$5.32M Buy
104,281
+2,860
+3% +$143K 0.09% 244
2013
Q3
$5.11M Buy
101,421
+4,360
+4% +$228K 0.1% 248
2013
Q2
$4.77M Buy
+97,061
New +$5.28M 0.09% 247

Other funds holding LLY

Baird's LLY Position: Q1 2015 in Review

Baird increased its Eli Lilly (LLY) stake by 0.32% in Q1 2015, buying an estimated $23.4K and bringing the position to 103,383 shares worth $7.51M. The position accounts for 0.08% of the portfolio, ranked #253.

Baird first reported a position in LLY in Q2 2013 and has held it in 8 quarters since. 1,117 funds tracked by Wall St. Rank hold LLY as of Q1 2015.

  • Baird held 103,383 shares of Eli Lilly worth $7.51M as of Q1 2015.
  • Baird bought 329 Eli Lilly shares in Q1 2015, an estimated $23.4K.
  • Eli Lilly made up 0.08% of Baird's portfolio in Q1 2015, its #253 holding.
  • Baird first reported a position in Eli Lilly in Q2 2013 and has held it in 8 quarters since.
  • 1,117 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.